These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7895059)

  • 21. SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.
    Steinberg R; Brun P; Fournier M; Souilhac J; Rodier D; Mons G; Terranova JP; Le Fur G; Soubrié P
    Neuroscience; 1994 Apr; 59(4):921-9. PubMed ID: 8058127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release.
    Mizoguchi H; Yamada K; Mouri A; Niwa M; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
    J Neurochem; 2007 Sep; 102(5):1548-1560. PubMed ID: 17472698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Responses of limbic and extrapyramidal neurotensin systems to stimulants of abuse. Involvement of dopaminergic mechanisms.
    Hanson GR; Singh N; Merchant K; Johnson M; Bush L; Gibb JW
    Ann N Y Acad Sci; 1992; 668():165-72. PubMed ID: 1361111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat.
    Hanson GR; Hoonakker AJ; Robson CM; McFadden LM; Frankel PS; Alburges ME
    J Pharmacol Exp Ther; 2013 Aug; 346(2):173-81. PubMed ID: 23685547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
    Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the limbic neurotensin systems induced by dopaminergic drugs.
    Merchant KM; Letter AA; Gibb JW; Hanson GR
    Eur J Pharmacol; 1988 Aug; 153(1):1-9. PubMed ID: 2905662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
    Ito K; Abekawa T; Koyama T
    Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
    Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-tetrahydropalmatine inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal activity and dopamine D3 receptor expression.
    Yun J
    Phytomedicine; 2014 Sep; 21(11):1287-91. PubMed ID: 25172791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.
    Igari M; Shen HW; Hagino Y; Fukushima S; Kasahara Y; Lesch KP; Murphy DL; Hall FS; Uhl GR; Ikeda K; Yaegashi N; Sora I
    Behav Pharmacol; 2015 Feb; 26(1-2):167-79. PubMed ID: 25485646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of methamphetamine self-administration on neurotensin systems of the basal ganglia.
    Frankel PS; Hoonakker AJ; Alburges ME; McDougall JW; McFadden LM; Fleckenstein AE; Hanson GR
    J Pharmacol Exp Ther; 2011 Mar; 336(3):809-15. PubMed ID: 21131268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis.
    Wagstaff JD; Gibb JW; Hanson GR
    Brain Res; 1996 May; 721(1-2):196-203. PubMed ID: 8793101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine.
    Hanson GR; Singh N; Bush L; Gibb JW
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1197-202. PubMed ID: 1722253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of potentially distinct neurotensin receptors in neurotensin-induced stimulation of striatal [3H]dopamine release evoked by KCl versus electrical depolarization.
    Heaulme M; Leyris R; Le Fur G; Soubrie P
    Neuropharmacology; 1997 Oct; 36(10):1447-54. PubMed ID: 9423933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological evidence that neurotensin mediates prolactin-induced activation of tuberoinfundibular dopamine neurons.
    Hentschel K; Cheung S; Moore KE; Lookingland KJ
    Neuroendocrinology; 1998 Aug; 68(2):71-6. PubMed ID: 9705573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
    Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microinfusions of neurotensin antagonist SR 48692 within the nucleus accumbens core impair spatial learning in rats.
    Tirado-Santiago G; Lázaro-Muñoz G; Rodríguez-González V; Maldonado-Vlaar CS
    Behav Neurosci; 2006 Oct; 120(5):1093-102. PubMed ID: 17014260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine.
    Panayi F; Dorso E; Lambás-Señas L; Renaud B; Scarna H; Bérod A
    Neuropsychopharmacology; 2002 Jan; 26(1):64-74. PubMed ID: 11751033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.